AMYLOIDOSIS

Clinical trials for AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 21 Not yet recruiting 2 Not yet finished but already full! 2 Completed 6 Terminated 1

Experimental drug aims to halt rare heart disease

Disease control Terminated

This study tested a drug called inotersen in 31 adults with TTR amyloid cardiomyopathy, a condition where abnormal protein builds up in the heart and causes progressive damage. The drug works by reducing the production of that protein in the liver. The goal was to see if it could…

Matched conditions: AMYLOIDOSIS

Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control

Last updated May 17, 2026 07:06 UTC

AMYLOIDOSIS

Get alerted when new AMYLOIDOSIS trials appear

Experimental drug aims to halt rare heart disease